Investigators assessed lifestyle and dietary patterns of more than 2000 men with nonmetastatic prostate cancer using three ...

Lisata Therapeutics Inc (LSTA) advances its pipeline with promising trial results for certepatide, despite facing financial ...

Results show a 24-month survival rate of 29.4% for mitazalimab in combination with mFOLFIRINOX, triple that of chemotherapy ...

The following is a summary of “Tacrolimus as first line therapy in a U.S. cohort of idiopathic inflammatory myopathies ...

A multimodal computational framework for patient stratification and prognosis prediction enables automatic identification of ...

Even just one dose of antenatal steroids administered mere hours before birth can improve outcomes for extremely preterm ...

Treatment with preventive heart medications can extend survival among males with Duchenne muscular dystrophy (DMD), a new ...

Alligator Bioscience has announced updated results from its phase 2 OPTIMIZE-1 study, showing the survival benefits of ...

Researchers conduct a retrospective, population-based cohort study of adult patients with metastatic breast cancer who underwent genomic profiling at academic institutions.

PDS Biotechnology (PDSB) announced the publication of clinical results in the Journal of the American Medical Association, JAMA, Oncology. The ...

Exercise PH — measured by the mPAP/CO slope — may predict survival in patients with normal or mildly elevated pulmonary arterial pressure.

Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral ...